ASMB.US Assembly Biosciences Inc

Healthcare Biotechnology USA Stocks
21.12 USD
Close of Nov 14, 2026
19.20 39.71
Market cap
USD 432M
P/E
28.2x
P/B
1.45x
ROE
-14.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is ASMB.US undervalued?

Graham number
Price21.12
Graham value15.68
Premium34.7%

ASMB.US trades 34.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Assembly Biosciences Inc fundamental analysis

No fundamental analysis for Assembly Biosciences Inc yet.

Assembly Biosciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Assembly Biosciences Inc

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infec…

Full company profile